Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment
Learn MoreFresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment
Learn MoreThe Conference Call on Q3 takes place on November 4, 2025
Learn MoreWhy I love home dialysis as a HCP working in nephrology
Learn MoreThe Challenges and Benefits of Generative AI in Kidney Care
Learn MoreObesity Trends, Anti-Obesity Drugs, and the Future of CKD Care
Learn MoreFresenius Medical Care publishes its key financial figures for the third quarter of 2025 on November 4, 2025
Learn More